← SynDRA
Tas-4464
SynDRA canonical compound SYN2467558 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | NAE1 |
|---|
| Mechanism of action | nedd activating enzyme inhibitor |
|---|
| Indication | multiple myeloma |
|---|
| Disease area | hematologic malignancy |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- NAE1
- SAE1
- UBA2
- UBA3
- UBE2F
Cross-references
Synonyms
- TAS4464
- YP58GC6E9L
- RefChem:932579
- MFCD32067967
- C21H23FN6O6S
- orb1146621
- SCHEMBL18297434
- SCHEMBL29406144
- BDBM320991
- GLXC-23533
- EX-A4922
- TAS4464?
- US10174040, Example 55
- AKOS040739964
- AC-36899
- DA-58290
- MS-29411
- HY-128586
- CS-0095952
- G16795
- EN300-22987979
- 7DM60E8064
- G16796
- SCHEMBL18297575
- T13090
- Z4119397720
- HY-128586A
- orb1309030
- MS-29991
- TAS4464 HCl
- DA-58291
- TAS-4464 hydrochloride
- TAS4464 (hydrochloride)
- CS-0095953
- TAS4464 hydrochloride
- C21H24ClFN6O6S
- AKOS040739953
Look up Tas-4464 in the interactive SynDRA portal →